In a recent Select Science Editorial Article, Előd Körtvély, principal scientist at Pharma Research and Early Development (pRED), Roche Innovation Center, Basel, shares how the team in Ophthalmology strives to develop novel therapeutic approaches for major eye diseases.
The article also deals with how the drug discovery process within the complement field has evolved and what the key challenges in this field are.
